CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $907,000 | -76.8% | 108,061 | -85.5% | 0.26% | -84.0% |
| Q1 2020 | $3,916,000 | +141.3% | 747,300 | +151.4% | 1.63% | +193.4% |
| Q4 2019 | $1,623,000 | +12.1% | 297,300 | 0.0% | 0.56% | +2.2% |
| Q3 2019 | $1,448,000 | -29.7% | 297,300 | 0.0% | 0.54% | -29.6% |
| Q2 2019 | $2,060,000 | -2.8% | 297,300 | -2.5% | 0.77% | -15.4% |
| Q1 2019 | $2,120,000 | +134.3% | 305,000 | +96.8% | 0.92% | +103.3% |
| Q4 2018 | $905,000 | -24.3% | 155,000 | -61.2% | 0.45% | -52.5% |
| Q2 2016 | $1,196,000 | +1413.9% | 400,000 | +700.0% | 0.95% | +1115.4% |
| Q3 2015 | $79,000 | -30.1% | 50,000 | +36.6% | 0.08% | -18.8% |
| Q2 2015 | $113,000 | – | 36,590 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 5,045,870 | $3,107,000 | 1.71% |
| ETF MANAGERS GROUP, LLC | 14,138,998 | $8,534,000 | 0.17% |
| Ikarian Capital, LLC | 948,526 | $584,000 | 0.09% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 318,668 | $196,000 | 0.03% |
| Platform Technology Partners | 45,000 | $28,000 | 0.01% |
| XTX Topco Ltd | 34,476 | $21,000 | 0.01% |
| PINNACLE ASSOCIATES LTD | 947,083 | $583,000 | 0.01% |
| Penserra Capital Management LLC | 537,236 | $330,000 | 0.01% |
| Mirae Asset Global Investments Co., Ltd. | 4,070,006 | $2,506,000 | 0.01% |
| Tekla Capital Management LLC | 154,310 | $95,000 | 0.00% |